These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27514623)

  • 1. Immunosuppressive Therapy and Interferon-1β in Acute Myocarditis.
    Gran F; Martínez-Villar M; Soler-Palacín P; Fernández-Polo A; Betrián P; Albert DC
    Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1106-1107. PubMed ID: 27514623
    [No Abstract]   [Full Text] [Related]  

  • 2. Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy.
    Dennert R; Velthuis S; Westermann D; Donker D; Schalla S; van Suylen RJ; Heymans S
    Antivir Ther; 2010; 15(4):681-5. PubMed ID: 20587861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir.
    Koenig T; Kempf T; Schultheiss HP; Cornberg M; Bauersachs J; Schäfer A
    Clin Res Cardiol; 2022 Feb; 111(2):233-236. PubMed ID: 34669016
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral treatment of myocarditis and acute dilated cardiomyopathy.
    Kühl U
    Heart Fail Clin; 2005 Oct; 1(3):467-74. PubMed ID: 17386869
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete recovery of a patient with cardiogenic shock due to parvovirus B19 fulminant myocarditis after treatment with extracorporeal membrane oxygenation and intravenous immunoglobulin.
    Drwiła R; Rubiś P; Kapelak B; Rudnicka-Sosin L; Pankuweit S; Gackowski A
    Pol Arch Med Wewn; 2015; 125(3):199-201. PubMed ID: 25666442
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of myocarditis.
    Schultheiss HP; Kühl U; Cooper LT
    Eur Heart J; 2011 Nov; 32(21):2616-25. PubMed ID: 21705357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].
    Pérez Calle JL; Salcedo M; Núñez O; Barrio J; Bañares R; de Diego A; Alvarez E; Palomo J; Clemente G
    Gastroenterol Hepatol; 2003 Jan; 26(1):26-8. PubMed ID: 12525325
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone.
    Stack J; McLaughlin P; Sinnot C; Henry M; MacEneaney P; Eltahir A; Harney S
    Scand J Rheumatol; 2010 Aug; 39(4):349-50. PubMed ID: 20476869
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute viral myocarditis. 2: Therapy].
    Schultheiss HP
    Fortschr Med; 1991 Jan; 109(3):49-50. PubMed ID: 2026376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil for prevention of acute rejection.
    Moore R; Griffin P; Darby C; Jurewicz A; Lord R
    Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827
    [No Abstract]   [Full Text] [Related]  

  • 11. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.
    Nigro G; Bastianon V; Colloridi V; Ventriglia F; Gallo P; D'Amati G; Koch WC; Adler SP
    Clin Infect Dis; 2000 Jul; 31(1):65-9. PubMed ID: 10913398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.
    Bojar M; Zajac M; Meluzínová E; Houžvičková E; Libertinová J; Lišková P; Mat'oška V; Nyč O; Mináriková M
    Mult Scler; 2010 Dec; 16(12):1529-30; author reply 1531-2. PubMed ID: 20829243
    [No Abstract]   [Full Text] [Related]  

  • 13. Childhood myocarditis and parvovirus B19 genotypes.
    Dina J; Villedieu F; Labombarda F; Freymuth F; de la Gastine G; Jokic M; Vabret A
    J Clin Virol; 2011 Jan; 50(1):61-4. PubMed ID: 20952249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-natriuretic peptide and left ventricular ejection fraction are complementary predictors.
    SoRelle R
    Circulation; 2003 Jun; 107(22):e9048-9. PubMed ID: 12796423
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunopathogenesis and treatment of myocarditis: the United States Myocarditis Treatment Trial.
    Mason JW
    J Card Fail; 1996 Dec; 2(4 Suppl):S173-7. PubMed ID: 8951576
    [No Abstract]   [Full Text] [Related]  

  • 16. A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy.
    Al-Abdwani RM; Khamis FA; Balkhair A; Sacharia M; Wali YA
    Pediatr Hematol Oncol; 2008 Sep; 25(7):699-703. PubMed ID: 18850484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Linicus Y; Vukadinovic AN; Fries P; Böhm M; Klingel K; Kindermann I
    Ther Umsch; 2016; 73(12):731-740. PubMed ID: 28462613
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice.
    Padalko E; Verbeken E; Matthys P; Aerts JL; De Clercq E; Neyts J
    BMC Microbiol; 2003 Dec; 3():25. PubMed ID: 14687413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies.
    Pauschinger M; Chandrasekharan K; Noutsias M; Kühl U; Schwimmbeck LP; Schultheiss HP
    Med Microbiol Immunol; 2004 May; 193(2-3):65-9. PubMed ID: 14722762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral myocarditis.
    Leonard EG
    Pediatr Infect Dis J; 2004 Jul; 23(7):665-6. PubMed ID: 15247607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.